Efeito antineoplásico do composto 4,2´,3´,4´-tetrametoxi chalcona em linhagem de neuroblastoma B103 de rato

Abstract

Neuroblastoma is the most frequently diagnosed malignancy in childhood. The term is commonly used to refer to a wide variety of neuroblastic tumors, including neuroblastomas, ganglioneuromas and ganglioneuroblastomas. Estimates show that 8 million children under 15 years of age per year are affected by this cancer, where 80% of cases are affected in up to 4 years of age, the tumor is malignant cells derived from embryonic arising from primary neuronal cells, since nodes adrenal medulla and sympathetic to other points. In this study, we assessed the cytotoxic potential of the compound 4,2 ', 3', 4'- tetrametoxchalcone in vitro model B103 rat neuroblastoma. Drug stock solutions were prepared at 50mM in dimethylsulphoxide (DMSO) and stored at - 20 ° C for the preparation of new concentrations (150μM, 100 mM, 75 mM and 50 mM). Cell viability was assayed from culture of glial cells from rat cortex. Cell migration assays and colony formation were also conducted. For statistical analysis, analysis of variance criterion (ANOVA) followed by Tukey test using the BioEstat 5.0 program was conducted. In the evaluation of cytotoxic effect of chalcones, it was observed that treatment with the compound 4,2’,3’,4’- tetrametoxchalcone showed no cytotoxic effect against normal cells of rat cortex for the concentrations tested, whereas in cell cultures neuroblastoma B103 was shown that the drug promotes cell death significantly.